Header Logo

Connection

Elizabeth Lieu to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Elizabeth Lieu has written about Carcinoma, Non-Small-Cell Lung.
Elizabeth Lieu
Connection Strength
0.282
Carcinoma, Non-Small-Cell Lung
  1. Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancer. Nat Metab. 2024 Jul; 6(7):1310-1328.
    View in: PubMed
    Score: 0.158
  2. The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer. Nat Metab. 2020 12; 2(12):1401-1412.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.